Finance

Beta
Lists
301111:SHE
Guangdong Lifestrong Pharmacy Co Ltd
CNÂ¥27.21
-1.59%
(-0.44) 1D
Jun 11, 1:11:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301111...
Open
CNÂ¥27.00
High
CNÂ¥28.17
Low
CNÂ¥26.73
Mkt. cap
4.52B
Avg. vol.
8.07M
Volume
3.11M
Dividend
0.18%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 11, 2026
52-wk high
CNÂ¥31.36
52-wk low
CNÂ¥14.80
EPS
-CNÂ¥0.03
Shares outstanding
160.00M
No. of employees
578
Open
CNÂ¥27.00
High
CNÂ¥28.17
Low
CNÂ¥26.73
Mkt. cap
4.52B
Avg. vol.
8.07M
Volume
3.11M
Dividend
0.18%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 11, 2026
52-wk high
CNÂ¥31.36
52-wk low
CNÂ¥14.80
EPS
-CNÂ¥0.03
Shares outstanding
160.00M
No. of employees
578
News stories
From sources across the web
About Guangdong Lifestrong Pharmacy Co Ltd
CEO-
Employees578
Founded1951
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
83.97M
73.63M
86.22M
66.18M
Cost of goods sold
29.50M
31.06M
36.43M
31.38M
Cost of revenue
29.50M
31.06M
36.43M
31.38M
Research and development expenses
2.07M
2.79M
1.81M
1.97M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
57.89M
44.36M
47.41M
37.19M
Operating expense
62.87M
46.79M
50.15M
39.78M
Total operating expenses
92.37M
77.84M
86.58M
71.16M
Operating income
-8.40M
-4.21M
-359.47K
-4.98M
Other non operating income
-115.24K
-337.45K
329.02K
-25.51K
EBT including unusual items
-8.88M
-2.77M
5.12M
-3.40M
EBT excluding unusual items
-7.71M
-3.13M
8.48M
-3.94M
Income tax expense
-2.82M
-1.37M
2.68M
203.50K
Effective tax rate
31.73%
49.30%
52.35%
-5.98%
Other operating expenses
1.12M
1.00M
1.12M
930.09K
Net income
-3.78M
-904.65K
3.64M
-3.31M
Net profit margin
-4.51%
-1.23%
4.22%
-5.00%
Earnings per share
-
-
-
-
Interest and investment income
1.66M
1.87M
9.55M
1.52M
Interest expense
-849.31K
-447.46K
-1.04M
-461.27K
Net interest expenses
811.90K
1.42M
8.51M
1.06M
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.87M
-1.53M
2.08M
-2.53M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more